148 related articles for article (PubMed ID: 37315872)
1. Identifying the role of hypoxia-related lncRNAs in pancreatic cancer.
Sun J; Zhu S
Genomics; 2023 Sep; 115(5):110665. PubMed ID: 37315872
[TBL] [Abstract][Full Text] [Related]
2. Positive Reciprocal Feedback of
Jin Y; Zhang Z; Yu Q; Zeng Z; Song H; Huang X; Kong Q; Hu H; Xia Y
Front Oncol; 2021; 11():761979. PubMed ID: 34881179
[TBL] [Abstract][Full Text] [Related]
3. LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α.
Zeng Z; Xu FY; Zheng H; Cheng P; Chen QY; Ye Z; Zhong JX; Deng SJ; Liu ML; Huang K; Li Q; Li W; Hu YH; Wang F; Wang CY; Zhao G
Theranostics; 2019; 9(18):5298-5314. PubMed ID: 31410216
[No Abstract] [Full Text] [Related]
4. Identification of key lncRNAs in the tumorigenesis of intraductal pancreatic mucinous neoplasm by coexpression network analysis.
Ding J; Li Y; Zhang Y; Fan B; Li Q; Zhang J; Zhang J
Cancer Med; 2020 Jun; 9(11):3840-3851. PubMed ID: 32239802
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein.
Liu M; Zhong J; Zeng Z; Huang K; Ye Z; Deng S; Chen H; Xu F; Li Q; Zhao G
Theranostics; 2019; 9(16):4795-4810. PubMed ID: 31367258
[No Abstract] [Full Text] [Related]
6. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1/AKT/mTOR axis.
Liu Y; Chen S; Cai K; Zheng D; Zhu C; Li L; Wang F; He Z; Yu C; Sun C
Cell Death Dis; 2022 Mar; 13(3):232. PubMed ID: 35283481
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway.
Li X; Deng SJ; Zhu S; Jin Y; Cui SP; Chen JY; Xiang C; Li QY; He C; Zhao SF; Chen HY; Niu Y; Liu Y; Deng SC; Wang CY; Zhao G
Oncotarget; 2016 Feb; 7(5):6000-14. PubMed ID: 26755660
[TBL] [Abstract][Full Text] [Related]
9. LncRNA co-expression network analysis reveals novel biomarkers for pancreatic cancer.
Giulietti M; Righetti A; Principato G; Piva F
Carcinogenesis; 2018 Jul; 39(8):1016-1025. PubMed ID: 29796634
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway.
Chen T; Liu R; Niu Y; Mo H; Wang H; Lu Y; Wang L; Sun L; Wang Y; Tu K; Liu Q
Cell Death Dis; 2021 Dec; 12(12):1152. PubMed ID: 34903711
[TBL] [Abstract][Full Text] [Related]
11. Identification of prognostic immune-related lncRNAs in pancreatic cancer.
Ma Y; He X; Di Y; Liu S; Zhan Q; Bai Z; Qiu T; Corpe C; Wang J
Front Immunol; 2022; 13():1005695. PubMed ID: 36420274
[TBL] [Abstract][Full Text] [Related]
12. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer.
Liu Y; Wang T; Fang Z; Kong J; Liu J
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1613-1626. PubMed ID: 35314871
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer.
Zhuang JY; Huang ZN; Weng ZJ; Liu MM; Huang XQ; He D; Shao CK; Dong M
Breast Cancer; 2024 Mar; 31(2):317-328. PubMed ID: 38310620
[TBL] [Abstract][Full Text] [Related]
14. A novel prognostic model associated with the overall survival in patients with breast cancer based on lipid metabolism-related long noncoding RNAs.
Shi GJ; Zhou Q; Zhu Q; Wang L; Jiang GQ
J Clin Lab Anal; 2022 Jun; 36(6):e24384. PubMed ID: 35441740
[TBL] [Abstract][Full Text] [Related]
15. Regulating the Expression of HIF-1α or lncRNA: Potential Directions for Cancer Therapy.
Zhang M; Zhang Y; Ding Y; Huang J; Yao J; Xie Z; Lv Y; Zuo J
Cells; 2022 Sep; 11(18):. PubMed ID: 36139386
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
17. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J
J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FRMD6-AS1 promotes hepatocellular carcinoma cell migration and stemness by regulating SENP1/HIF-1α axis.
Sun W; Lei X; Lu Q; Wu Q; Ma Q; Huang D; Zhang Y
Pathol Res Pract; 2023 Mar; 243():154377. PubMed ID: 36827886
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HAS2-AS1 mediates hypoxia-induced invasiveness of oral squamous cell carcinoma.
Zhu G; Wang S; Chen J; Wang Z; Liang X; Wang X; Jiang J; Lang J; Li L
Mol Carcinog; 2017 Oct; 56(10):2210-2222. PubMed ID: 28485478
[TBL] [Abstract][Full Text] [Related]
20. Positive feedback regulation of lncRNA TPT1-AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer.
Cheng C; Liu D; Liu Z; Li M; Wang Y; Sun B; Kong R; Chen H; Wang G; Li L; Hu J; Li Y; Chen H; Zhao Z; Zhang T; Zhu S; Pan S
Cancer Sci; 2022 Sep; 113(9):2986-3001. PubMed ID: 35534983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
